The company said the approval opens up India's large consumer market for its plant-based Vitamin D3 solution and reinforces its position in science-backed Vitamin D3 products. Fermenta added that the product is protected by an Indian process patent and is developed and manufactured in India.
Managing director Prashant Nagre said the approval will allow the company to address the country's widespread Vitamin D deficiency by offering a sustainable, scalable and affordable plant-based Vitamin D3 solution. He added that VITADEE Green supports the government's 'Make in India' initiative by providing a domestically manufactured alternative for Indian formulators.
Fermenta Biotech said the approval also provides vegetarian consumers with access to a plant-based Vitamin D3 option and supports the broader objective of addressing Vitamin D deficiency through food fortification.
Fermenta Biotech manufactures nutritional ingredients, active pharmaceutical ingredients (APIs), intermediates and nutritional premixes, while also offering green chemistry and environmental solutions. The company operates manufacturing facilities in Himachal Pradesh, Gujarat and Andhra Pradesh, supported by an R&D centre in Thane, and serves more than 400 customers across over 60 countries.
On a consolidated basis, Fermenta Biotech's net profit declined 44.20% to Rs 19.19 crore while net sales declined 13.06% to Rs 121.58 crore in Q4 March 2026 over Q4 March 2025.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."